Standardized to corosolic acid and traditionally used to support healthy metabolic processes
The ATTAIN-MAINTAIN trial asked a question nobody had answered before: can people who lose weight on injectable GLP-1 medications maintain that weight loss after switching to an oral pill
If it happens as a result of other metabolic diseases, this is secondary carnitine deficiency
There are two types: gastric inhibitory polypeptide (GIP), secreted from K cells present in the upper intestine, and glucagon-like peptide-1 (GLP-1), secreted from L cells present in the lower intestine and large intestine 25
9: Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
That track record matters